by Rakovina Therapeutics | Jul 10, 2025 | Uncategorized
DOWNLOAD Vancouver, British Columbia, July 10, 2025 — Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered...
by Rakovina Therapeutics | Jul 1, 2025 | Uncategorized
Download Vancouver, British Columbia, June 30, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery,...
by Rakovina Therapeutics | Jul 1, 2025 | Uncategorized
Download Vancouver, British Columbia, June 30, 2025 – Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”) announces that it will apply to the TSX Venture Exchange (the “Exchange”) to amend the terms of certain outstanding warrants and convertible...
by Rakovina Therapeutics | Jun 26, 2025 | Uncategorized
Download Vancouver, British Columbia, June 25, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery...
by Rakovina Therapeutics | Jun 20, 2025 | Uncategorized
Download VANCOUVER, B.C., June 20, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE:7JO) (“Rakovina” or the “Company”) is pleased to announce that the effective date for the previously announced share consolidation (the...
by Rakovina Therapeutics | Jun 20, 2025 | Uncategorized
Download Vancouver, British Columbia – June 12, 2025 – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery,...